Centaurus Financial Inc. Sells 952 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Centaurus Financial Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 15.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 5,391 shares of the healthcare conglomerate’s stock after selling 952 shares during the period. Centaurus Financial Inc.’s holdings in UnitedHealth Group were worth $3,152,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after purchasing an additional 35,533 shares during the last quarter. International Assets Investment Management LLC grew its holdings in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after acquiring an additional 21,149 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its holdings in UnitedHealth Group by 19.2% in the second quarter. Canada Pension Plan Investment Board now owns 3,129,749 shares of the healthcare conglomerate’s stock valued at $1,593,856,000 after acquiring an additional 504,461 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on UNH shares. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Truist Financial reissued a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, UBS Group lowered their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Trading Down 1.1 %

UnitedHealth Group stock opened at $590.87 on Friday. The business has a 50-day simple moving average of $582.63 and a two-hundred day simple moving average of $552.95. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market cap of $543.77 billion, a P/E ratio of 38.49, a P/E/G ratio of 1.75 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the firm earned $6.56 EPS. The firm’s revenue was up 9.2% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.